Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PepsiCo
PEP
$192B
| $16.8M | 0.01% |
126,826
-956,178
| -88% | -$126M |
|
|
EGRX
927
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $16.8M | 0.01% |
349,500
+60,900
| +21% | +$3.04M |
|
928
Americold
COLD
$4.17B
| $16.8M | 0.01% |
461,700
+279,500
| +153% | +$9.55M |
|
929
TC Energy
TRP
$66.3B
| $16.7M | 0.01% |
392,203
+359,203
| +1,088% | +$16.1M |
|
930
NorthWestern Energy
NWE
$4.34B
| $16.7M | 0.01% |
306,926
-37,904
| -11% | -$2.2M |
|
931
KRONOS Worldwide
KRO
$905M
| $16.7M | 0.01% |
1,606,700
-28,300
| -2% | -$265K |
|
932
OceanFirst Financial
OCFC
$1.85B
| $16.7M | 0.01% |
946,917
-56,500
| -6% | -$905K |
|
933
Columbia Financial
CLBK
$1.21B
| $16.7M | 0.01% |
1,195,732
+184,100
| +18% | +$2.57M |
|
934
Mine Safety
MSA
$7.32B
| $16.7M | 0.01% |
+145,800
| New | +$16.2M |
|
|
PDCO
935
DELISTED
Patterson Companies, Inc.
PDCO
| $16.6M | 0.01% |
755,304
+679,060
| +891% | +$11.9M |
|
936
Powell Industries
POWL
$7.43B
| $16.6M | 0.01% |
1,818,405
-72,000
| -4% | -$612K |
|
937
Heartland Express
HTLD
$950M
| $16.6M | 0.01% |
795,627
+144,300
| +22% | +$2.9M |
|
938
Buckle
BKE
$2.33B
| $16.6M | 0.01% |
1,056,150
-476,061
| -31% | -$7.13M |
|
939
KNOT Offshore Partners
KNOP
$362M
| $16.5M | 0.01% |
1,200,304
-258,200
| -18% | -$3.54M |
|
940
Knight Transportation
KNX
$11.6B
| $16.5M | 0.01% |
+394,727
| New | +$15.1M |
|
941
Euronet Worldwide
EEFT
$2.66B
| $16.5M | 0.01% |
171,745
-92,800
| -35% | -$8.57M |
|
942
Marriott Vacations Worldwide
VAC
$4.1B
| $16.3M | 0.01% |
198,861
+141,800
| +249% | +$11.6M |
|
943
SEI Investments
SEIC
$12.7B
| $16.2M | 0.01% |
294,926
-601,500
| -67% | -$31.4M |
|
944
Southwest Gas
SWX
$6.68B
| $16.1M | 0.01% |
+233,500
| New | +$17M |
|
945
Chefs' Warehouse
CHEF
$4.53B
| $16.1M | 0.01% |
1,184,100
+37,500
| +3% | +$518K |
|
946
Wabash National
WNC
$507M
| $16.1M | 0.01% |
1,512,400
+369,300
| +32% | +$3.25M |
|
947
Allegion
ALLE
$14.2B
| $16.1M | 0.01% |
157,100
-278,700
| -64% | -$27.5M |
|
948
Artesian Resources
ARTNA
$362M
| $16M | 0.01% |
440,111
+28,861
| +7% | +$1.01M |
|
|
ATCO
949
DELISTED
Atlas Corp.
ATCO
| $16M | 0.01% |
2,099,307
-280,800
| -12% | -$2.04M |
|
950
iRadimed
IRMD
$1.11B
| $15.9M | 0.01% |
686,357
+60,200
| +10% | +$1.29M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.